Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

GHRS - GH Research PLC


IEX Last Trade
10.39
-0.580   -5.582%

Share volume: 21,859
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$10.97
-0.58
-5.29%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-8.54%
1 Month
-13.79%
3 Months
-22.39%
6 Months
27.58%
1 Year
-1.87%
2 Year
-30.83%
Key data
Stock price
$10.39
P/E Ratio 
0.00
DAY RANGE
$10.17 - $11.07
EPS 
$0.00
52 WEEK RANGE
$5.05 - $14.99
52 WEEK CHANGE
$0.01
MARKET CAP 
546.296 M
YIELD 
N/A
SHARES OUTSTANDING 
52.028 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.51
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$20,158
AVERAGE 30 VOLUME 
$27,173
Company detail
CEO: Theis Terwey
Region: US
Website:
Employees: 9
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.

Recent news